Rote William E.'s Form 4 filing
Travere Therapeutics, Inc. (TVTX) · filed Sep 5, 2023
- Accession no.
- 0001209191-23-048257
- Filed
- Sep 5, 2023
- Trade date
- Aug 31-Sep 5, 2023
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $26.7K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rote William E.CIK 0001698262 | Officer (Senior Vice President, R&D) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 31, 2023 | Common Stock | AGrant or awardAcquired | +3,300 | $0.00 | $0 | 62,988 | Direct | |
| Sep 5, 2023 | Common Stock | SSaleDisposed | −1,815 | $14.71 | −$26,698.65 | 61,173 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.